Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/HER2-negative breast...
The benefit of anthracyclines for patients with high 21-gene recurrence score (RS) is unclear, despite the widespread use of RS to guide adjuvant chemotherapy treatment for hormone receptor (HR)-po...
annalsofoncology.org